MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 9 filers reported holding MONOPAR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rappaport Reiches Capital Management, LLC | 10,695 | $9,144 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,733 | $3,192 | 0.00% |
| VANGUARD GROUP INC | 99,176 | $84,796 | 0.00% |
| FMR LLC | 150 | $128 | 0.00% |
| WELLS FARGO & COMPANY/MN | 33 | $28 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 41,892 | $35,817 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 32,761 | $28,011 | 0.00% |
| MORGAN STANLEY | 4,000 | $3,420 | 0.00% |
External links
This page lists MONOPAR THERAPEUTICS INC's shareholders in Q2 2023. To view MONOPAR THERAPEUTICS INC's shareholder history, click here.